These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7017401)

  • 1. Clinical trial in Duchenne dystrophy. I. The design of the protocol.
    Brooke MH; Griggs RC; Mendell JR; Fenichel GM; Shumate JB; Pellegrino RJ
    Muscle Nerve; 1981; 4(3):186-97. PubMed ID: 7017401
    [No Abstract]   [Full Text] [Related]  

  • 2. Human growth hormone and estrogens in boys with Duchenne muscular dystrophy.
    Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
    Arch Phys Med Rehabil; 1973 Jun; 54(6):248-53. PubMed ID: 4708006
    [No Abstract]   [Full Text] [Related]  

  • 3. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy].
    Moser H; Mumenthaler M; Wiesmann U
    Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948
    [No Abstract]   [Full Text] [Related]  

  • 5. Tabulation of findings in the muscular dystrophies and in myotonia dystrophica.
    Danowski TS; Wissinger HA; Hohmann TC; Gerneth JA; Folkers K; Vester JW; Fisher ER
    Arch Phys Med Rehabil; 1971 May; 52(5):193-200. PubMed ID: 4931852
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique.
    Moosa A; Brown BH; Dubowitz V
    J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):841-4. PubMed ID: 4647857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis between Duchenne and Becker types muscular dystrophy.
    Ishpekova B; Milanov I; Christova LG; Alexandrov AS
    Electromyogr Clin Neurophysiol; 1999; 39(5):315-8. PubMed ID: 10422002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity in Duchenne dystrophy.
    Hyser CL; Province M; Griggs RC; Mendell JR; Fenichel GM; Brooke MH; Miller JP; Polakowska R; Doherty RA; Quirk S
    Ann Neurol; 1987 Oct; 22(4):553-5. PubMed ID: 3435074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative EMG as a method of carrier detection in X-linked muscular dystrophy.
    Gardner-Medwin D
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):401. PubMed ID: 4176582
    [No Abstract]   [Full Text] [Related]  

  • 10. Duchenne muscular dystrophy, preclinical diagnosis.
    Murdoch JL
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):110. PubMed ID: 5173117
    [No Abstract]   [Full Text] [Related]  

  • 11. Muscular dystrophy: diagnosis and treatment.
    Ketenjian AY
    Orthop Clin North Am; 1978 Jan; 9(1):25-42. PubMed ID: 643265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I; Wierzbicka M; Jozwik A; Szmidt-Salkowska E; Borkowska J
    Electromyogr Clin Neurophysiol; 1982; 22(6):445-57. PubMed ID: 7140630
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperestrogenemia in Duchenne muscular dystrophy (DMD)].
    Usuki F; Nakazato O; Osame M; Igata A
    Rinsho Shinkeigaku; 1985 Jun; 25(6):711-5. PubMed ID: 4053465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Limb-girdle muscular dystrophy in MRI].
    Herzog H; Schröder RJ
    Rofo; 2003 Oct; 175(10):1432-4. PubMed ID: 14556115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
    Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
    An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dystrophin gene expression in patients with Duchenne muscular dystrophy after myoblast transplantation].
    Shishkin SS; Terekhov SM; Krokhina TB; Shakhovskaia NI; Podobedova AN; Linnaia GF; Tarasov VI; Ovchinnikov VI; Krakhmaleva IN; Zakharov SF; Ershova ES; Limborskaia SA; Pogoda TV; Zotikov EA; Kut'ina RM; Tarksh MA; Sukhorukov VS; Gerasimova NL
    Genetika; 2001 Aug; 37(8):1104-11. PubMed ID: 11642111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency of blood flow in patients with hereditary muscular dystrophy].
    Schroeder W; Treumann F; Demos J
    Arztl Forsch; 1969 Jun; 23(6):185-90. PubMed ID: 5394750
    [No Abstract]   [Full Text] [Related]  

  • 19. Early diagnosis and treatment of rapidly developing Duchenne De Boulogne type myopathy (type DDB I).
    Demos J
    Am J Phys Med; 1971 Dec; 50(6):271-84. PubMed ID: 5141650
    [No Abstract]   [Full Text] [Related]  

  • 20. Body-potassium concentation and rubidium metabolism determined by whole-body counting in Duchenne muscular dystrophy and its genetic carrier state.
    Nagai T; Sugita H; Iinuma TA; Furukawa T; Yashiro S
    J Nucl Med; 1969 Jan; 10(1):1-7. PubMed ID: 5797554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.